Pharmaceutical and nutraceutical potential of the halophytic plant Carpobrotus rossii by Pirie, A
  
 
 
The pharmaceutical and nutraceutical potential of the halophytic plant 
Carpobrotus rossii 
 
Adam Douglas Pirie 
BLWSc, Sydney 
 
Submitted in fulfilment of the requirements for the degree of 
Doctor of Philosophy 
University of Tasmania 
 
June 2014 
 
i 
 
 
 
Statement of Originality 
This thesis contains no material which has been accepted for a degree or diploma by the University or 
any other institution, except by way of background information and duly acknowledged in the thesis, 
and to the best of my knowledge and belief no material previously published or written by another 
person except where due acknowledgement is made in the text of the thesis, nor does the thesis 
contain any material that infringes copyright. 
 
Adam Douglas Pirie        5
th
 June 2014 
Authority of Access  
This thesis is not to be made available for loan or copying for two years following the date this 
statement was signed. Following that time the thesis may be made available for loan and 
limited copying and communication in accordance with the Copyright Act 1968. 
 
 
Adam Douglas Pirie        5
th
 June 2014 
 
Statement of Ethical Conduct 
The research associated with this thesis abides by the international and Australian codes on 
human and animal experimentation, the guidelines by the Australian Government's Office of 
the Gene Technology Regulator and the rulings of the Safety, Ethics and Institutional Biosafety 
Committees of the University. All animal experiments conducted in this thesis were done under 
the approval of the University of Tasmania's Animal Ethics Committee; approval numbers 
A0010751 and A0011684 respectively.  
 
ii 
 
 
 
Statement of Co-Authorship 
Given that this thesis is presented as a series of papers, either published, in press or submitted, 
statements of co-authorship are provided for each chapter. Due to this thesis format, some 
repetition is inevitable. 
The following people and institutions contributed to the publication or preparation of the work 
undertaken as part of this thesis: 
 
Candidate: Adam Pirie,  
 
Author 1: Christian Narkowicz
1
,  
Author 2: Glenn Jacobson
1
,  
Author 3: Sergey Shabala
2
,  
Author 4: Michelle Keske
3
,  
Author 5: Dominic Geraghty
4
,  
Author 6: Noel Davies
5
,  
Author 7: James Horne
5
,  
Author 8: Pavel Nesterenko
6
,  
Author 9: Kiran Ahuja
4
,  
Author 10: David Parsons
2
,  
Author 11: Murray Adams
4
,  
Author 12: Cecilia Shing
4
,  
Author 13: Jolanda Renggli
1
,  
Author 14: Nynke Jager
1
,  
Author 15: Anton Peristy
6
. 
 
 
1
School of Pharmacy, University of Tasmania; 
2
School of Agricultural Science University of 
Tasmania; 
3
Menzies Research Institute, University of Tasmania;
 4
School of Human and Life 
Sciences, University of Tasmania; 
5
Central Science Laboratory, University of Tasmania; 
6
School of Chemistry, University of Tasmania. 
 
 
 
 
  
iii 
 
 
Manuscripts arising from this thesis and statement of contribution 
 
Paper 1. “Ecophysiology of Carpobrotus rossii in Tasmania: Linking plant’s antioxidant activity with 
a natural habitat  
Chapter 2,  
Candidate was the primary author, who in conjunction with authors1-3 contributed to experimental 
design and development. Authors 1,3 and 13 assisted in the conduction of experiments. Author 10 
provided expertise with statistical analysis. Author 3 provided input on data interpretation and 
presentation. Some of the flavonoid, tannin and DPPH assay field survey data described in this paper 
were generated as part of author 13’s Master’s thesis. However, generation of the full dataset and 
statistical analysis was undertaken during the candidate’s PhD candidature. 
 
Paper 2. “Flavonoid and tannin production of Carpobrotus rossii is modulated by environmental 
conditions” 
Chapter 2,  
Candidate was the primary author, who in conjunction with authors1-3 contributed to experimental 
design and development. Authors 1,3 and 13 assisted in the conduction of experiments. Author 10 
provided specialist expertise with statistical analysis. Author 3 provided input on data interpretation 
and presentation. Some of the flavonoid, tannin and DPPH assay field survey data described in this 
paper were generated as part of author 13’s Master’s thesis, however generation of the full dataset 
and statistical analysis was undertaken during  the candidate’s PhD candidature. 
 
Chapter 3. Low-temperature and ultraviolet B exposure induce separate and structurally unrelated 
biochemical responses in Carpobrotus rossii  
Candidate was the primary author, who in conjunction with authors 1-3 contributed to experimental 
design and development and refinement. Authors 6, 8 and 15 provided specialist instrumentation 
and analytical skills. Authors 1,2 and 6 provided input on data interpretation. Author 3 provided input 
on data interpretation and presentation. 
 
 
 
 
iv 
 
 
 
Chapter 4. Pirieol A from Carpobrotus rossii, a novel spinacetin glycoside containing apiose and 
HMG moieties. 
Candidate was the primary author, who in conjunction with authors 1, 2, 14 and 7 contributed to 
experimental design and development and refinement. Author 14 undertook the UV spectrum 
analysis, hydrolysis and comparison to commercial standards, and determination of aglycone 
structure work described in this chapter (in conjunction with authors 1, 6 and 7), the results of which 
are reported in her Master's thesis. The candidate propagated the high purity plant and undertook 
preliminary purification of the extract used to determine the structure of the entire compound. 
Author 8 undertook the final large-scale fractionation step to produce a high-purity sample for NMR 
analysis. Authors 7,6 and 1 provided specialist instrumentation, analytical and data interpretation 
skills. 
 
Chapter 5. Hypolipidaemic effect of crude extract from Carpobrotus rossii (pigface) in healthy rats 
Candidate was the primary author, who in conjunction with authors 1, 2 and 5 contributed to 
experimental design and development. Authors 5 and 12 assisted in the conduction of experiments. 
Authors 6, 9 and 11 provided specialist analytical expertise. Authors 5, 9, 11 and 12 provided input on 
data interpretation and presentation. 
 
Chapter 6. Flavonoids from Carpobrotus rossii improve glucose clearance in insulin resistant 
animals 
Candidate was the primary author, who in conjunction with authors 1, 2, 4 and 5 contributed to 
experimental design and development. Author 4 assisted in the conduction of experiments. Authors 9 
provided specialist analytical and statistical expertise. 
 
 
 
 
 
v 
 
 
 
 
We the undersigned agree with the above stated “proportion of work undertaken” for each of the 
above published (or submitted) peer-reviewed manuscripts contributing to this thesis: 
 
Signed:     
Candidate Adam Douglas Pirie 
 
Author 1   _______________________ 
 
Author 2   _______________________ 
 
Author 3   _______________________ 
 
Author 4   _______________________ 
 
Author 5   _______________________ 
 
Author 6   _______________________ 
 
Author 7  _______________________ 
 
Author 8   _______________________ 
 
Author 9   _______________________ 
 
Author 10  _______________________ 
 
Author 11  _______________________ 
 
Author 12  _______________________ 
 
Author 13  _______________________ 
 
Author 14  _______________________ 
 
Author 15  _______________________ 
  
vi 
 
 
Acknowledgements 
The list of people I owe a debt of gratitude for their involvement in and/or support of this work is 
long and extensive. 
Firstly I would like to thank both of my School of Pharmacy supervisors Dr Glenn Jacobson and 
Dr Christian Narkowicz for their support and encouragement whilst pursuing such a multi-disciplinary 
project. To my other supervisors Prof Dominic Geraghty, Dr Michelle Keske and Prof Sergey Shabala, 
thank you for your enthusiasm and willingness to support such an unconventional project; and for 
providing the individual expertise and guidance needed to enable this thesis to happen successfully. 
Your support, insight and guidance, especially when things weren't running as planned was truly 
appreciated. You are all well and truly been responsible for me going from "soil boy" to "drug-
discovery child".  
To the Utas CSL staff, especially A/Prof Noel Davies and Dr James Horne, your approachability, 
ability and willingness to provide mentoring, in addition to your technical prowess, is very much 
appreciated.  
To my other co-authors. Thankyou for your approachability, willingness to be involved in various 
facets of the project and ability to provide input, expertise and guidance when I knocked on your door 
needing a technique or equipment to "plug and play" with my samples. Without you, many of the 
questions asked during this work would still remain unanswered. 
Dr Peter Traill, Heather Galloway and Mr Phillip Andrews, Dr Dino Premilovac, Eloise Bradley and 
the other members of the MRG, in addition to Drs Nuri Güven, Jason Smith, Rahul Patel and Mr 
Steve Weston. Your assistance, support, provision of logistics for this project has been invaluable as 
has your tolerance of me asking  "rookie" questions when my brain occasionally decided to go on 
vacation, so thank you. 
Mum, Dad, Jarrod and Rhys, thank you for being sounding boards, supporters, listening to me 
vent and generally letting me know that you care.  
Most of all I would like to thank my wonderful fiancé Lucy, without you none of this would have 
happened and I will be forever grateful for your support. You have no idea how much I am looking 
forward to our next adventure(s) together. 
  
vii 
 
 
Contents 
Statement of Originality ..................................................................................................... i 
Authority of Access ............................................................................................................ i 
Statement of Ethical Conduct ............................................................................................. i 
Statement of Co-Authorship .............................................................................................. ii 
Manuscripts arising from this thesis and statement of contribution .................................. iii 
Acknowledgements .......................................................................................................... vi 
PhD overview ................................................................................................................... xx 
1.1 The Vascular System ...................................................................................................1 
1.1.1 Cardiovascular system ......................................................................................1 
1.1.1.1 Vessel Anatomy ........................................................................................1 
1.1.1.1.1 The Endothelium ......................................................................................4 
1.1.2 Glucose delivery and uptake .............................................................................7 
1.1.2.1 Insulin signalling .......................................................................................8 
1.1.3 Inflammation and the Disease process ..............................................................9 
1.1.3.1 Causes of endothelial dysfunction ........................................................... 10 
1.1.3.2 Platelets ................................................................................................... 14 
1.1.3.3 Lipoproteins ............................................................................................ 14 
1.1.3.4 Hyperlipidaemia ...................................................................................... 16 
1.1.3.5 Hyperglycaemia....................................................................................... 17 
1.1.4 Treatment ....................................................................................................... 18 
1.1.4.1 Lowering of low-density lipoprotein ....................................................... 21 
1.1.4.2 Lowering blood glucose .......................................................................... 23 
1.1.4.3 Reducing Oxidative Stress ....................................................................... 24 
1.1.4.4 Increasing NO production........................................................................ 25 
1.1.4.5 Alteration of signal transduction and receptors ........................................ 25 
1.2 Potential for C. rossii as a nutraceutical product ........................................................ 27 
1.2.1.1 The plant ................................................................................................. 28 
1.3 Plant Metabolism ....................................................................................................... 30 
1.3.1 ROS generation and function in planta ........................................................... 30 
1.3.2 ROS induced damage ..................................................................................... 35 
viii 
 
 
1.3.2.1 Low Temperature, high light conditions and exposure to ultra-violet light
 38 
1.3.2.2 High Sodium and low potassium ............................................................. 40 
1.3.3 Antioxidants to combat ROS .......................................................................... 41 
1.3.3.1 Flavonoid structure .................................................................................. 43 
1.3.3.2 Role of flavonoids in Planta .................................................................... 45 
1.4 C. rossii novel flavonoid - pharmaceutical potential .................................................. 46 
1.5 PhD Aims .................................................................................................................. 48 
2 Flavonoid and tannin production of Carpobrotus rossii is modulated by environmental 
conditions ............................................................................................................................. 49 
2.1 Abstract ..................................................................................................................... 49 
2.2 Introduction ............................................................................................................... 50 
2.3 Material and Methods ................................................................................................ 53 
2.3.1 Sampling methods and location ...................................................................... 53 
2.3.2 Chlorophyll fluorescence ................................................................................ 53 
2.3.3 Soil Sampling ................................................................................................. 54 
2.3.4 Stomata density .............................................................................................. 54 
2.3.5 Leaf sap nutrient analysis and osmolarity ....................................................... 54 
2.3.6 Flavonoid concentration by HPLC .................................................................. 54 
2.3.7 Antioxidant activity assessment ...................................................................... 55 
2.3.8 Glasshouse experiment ................................................................................... 56 
2.3.9 Statistical Analysis ......................................................................................... 57 
2.4 Results ....................................................................................................................... 58 
2.4.1 Field Survey ................................................................................................... 58 
2.4.2 Biomass and flavonoid production under controlled conditions ...................... 63 
2.4.3 Leaf ionic relations under saline conditions .................................................... 71 
2.5 Discussion ................................................................................................................. 74 
2.6 Conclusion ................................................................................................................ 77 
2.7 Acknowledgements ................................................................................................... 78 
3 Low-temperature and ultraviolet B exposure induce separate and structurally unrelated 
biochemical responses in Carpobrotus rossii ....................................................................... 79 
ix 
 
 
3.1 Abstract ..................................................................................................................... 79 
3.2 Introduction ............................................................................................................... 80 
3.3 Experimental ............................................................................................................. 81 
3.3.1 Materials and reagents .................................................................................... 81 
3.3.2 Low Temperature experiments ....................................................................... 82 
3.3.2.1 Plant propagation ..................................................................................... 82 
3.3.2.2 Sample collection .................................................................................... 82 
3.3.3 Ultraviolet B radiation exposure ..................................................................... 83 
3.3.3.1 Plant propagation and growing conditions- Ultra-violet B exposure ........ 83 
3.3.3.2 Sample collection .................................................................................... 83 
3.3.4 Statistical analysis ........................................................................................... 83 
3.4 Results ....................................................................................................................... 83 
3.4.1 Temperature Experiments ............................................................................... 83 
3.4.1.1 Temperatures and growing conditions ..................................................... 83 
3.4.1.2 Flavonoid production ............................................................................... 84 
3.4.1.3 2,2-Diphenyl-1-picrylhydrazyl (DPPH) assay performance .................... 86 
3.4.1.4 Antioxidant Activity ................................................................................ 86 
3.4.1.5 Biomass production ................................................................................. 87 
3.4.1.6 Nutrient levels ......................................................................................... 87 
3.4.2 Ultra-violet B exposure ................................................................................... 88 
3.4.2.1 Flavonoid and betalain production ........................................................... 88 
3.4.2.2 DPPH Antioxidant Activity ..................................................................... 88 
3.4.2.3 Effect of UVB on Biomass ...................................................................... 88 
3.4.2.4 Nutrient levels ......................................................................................... 88 
3.5 Discussion ................................................................................................................. 89 
3.5.1 Mechanisms and specificity of ROS generation .............................................. 89 
3.5.2 Nutritional levels, sodium and potassium, biomass ......................................... 93 
3.5.3 Antioxidant activity ........................................................................................ 95 
3.6 Conclusion ................................................................................................................ 96 
3.6.1 Acknowledgements ........................................................................................ 96 
x 
 
 
4 Pirieol A from Carpobrotus rossii, a novel spinacetin glycoside containing apiose and 
HMG moieties. ..................................................................................................................... 97 
4.1 Abstract ..................................................................................................................... 97 
4.2 Introduction ............................................................................................................... 98 
4.3 Material and methods ................................................................................................ 99 
4.3.1 General experimental procedures .................................................................... 99 
4.4 Results and Discussion ............................................................................................ 101 
4.5 Acknowledgements ................................................................................................. 109 
5 Hypolipidaemic effect of crude extract from Carpobrotus rossii (pigface) in healthy rats
 110 
5.1 Abstract ................................................................................................................... 110 
5.2 Introduction ............................................................................................................. 111 
5.3 Materials and Methods ............................................................................................ 112 
5.3.1 Materials and Reagents ................................................................................. 112 
5.3.2 Preparation and flavonoid content of C. rossii extract. .................................. 112 
5.3.3 Animal treatment .......................................................................................... 113 
5.3.4 Blood and tissue collection ........................................................................... 113 
5.3.5 In Vitro vascular responsiveness ................................................................... 114 
5.3.6 Lipid, cholesterol, glucose analysis .............................................................. 114 
5.3.7 Determination of kidney HMG levels ........................................................... 115 
5.3.8 Statistical analysis ......................................................................................... 115 
5.4 Results ..................................................................................................................... 116 
5.5 Discussion ............................................................................................................... 120 
5.6 Conclusion .............................................................................................................. 122 
5.7 Acknowledgements ................................................................................................. 123 
6 Flavonoids from Carpobrotus rossii improve glucose clearance in insulin resistant 
animals ............................................................................................................................... 124 
6.1 Abstract ................................................................................................................... 124 
6.2 Introduction ............................................................................................................. 125 
6.3 Materials and Methods ............................................................................................ 127 
6.3.1 Materials and Reagents ................................................................................. 127 
xi 
 
 
6.3.2 Preparation of crude and flavonoid-rich C. rossii extracts............................. 127 
6.3.3 Animal models .............................................................................................. 129 
6.3.3.1 Animal Housing .................................................................................... 129 
6.3.3.2 Insulin resistance model (high fat diet C57/BL6 mice) .......................... 129 
6.3.3.3 Hyperlipidaemia model (high cholesterol diet rats) ............................... 130 
6.3.3.4 Blood collection and measurement ........................................................ 131 
6.3.4 Statistical analysis ........................................................................................ 131 
6.4 Results ..................................................................................................................... 132 
6.4.1 Insulin resistant (C57/BL6) mice .................................................................. 132 
6.4.1.1 Body weight gain, food and water consumption .................................... 132 
6.4.1.2 Glucose clearance .................................................................................. 133 
6.4.1.3 Blood lipids ........................................................................................... 134 
6.4.2 Hyperlipidaemic rats ..................................................................................... 134 
6.4.2.1 Body weight gain, food and water consumption .................................... 134 
6.4.2.2 Blood lipids ........................................................................................... 135 
6.5 Discussion ............................................................................................................... 136 
6.5.1 C57/BL6 mice body weight gain, energy and water consumption. ............... 136 
6.5.2 C57/BL6 Mice glucose tolerance .................................................................. 136 
6.5.3 C57/BL6 Mice blood lipids .......................................................................... 137 
6.5.4 Sprague-Dawley weight gain, energy and water consumption ...................... 138 
6.5.5 Sprague-Dawley at blood lipids .................................................................... 138 
6.6 Conclusion .............................................................................................................. 139 
6.7 Acknowledgements ................................................................................................. 139 
6.8 Declaration of interests ............................................................................................ 139 
6.9 Contributors statement ............................................................................................. 139 
7 Thesis overview and direction of future work ............................................................ 140 
7.1 Overview ................................................................................................................. 140 
7.2 Thesis Limitations ................................................................................................... 140 
7.3 Future directions ...................................................................................................... 142 
7.4 Conclusion .............................................................................................................. 144 
8 References .................................................................................................................. 145 
xii 
 
 
9 Appendices ................................................................................................................. 173 
9.1 Appendix Chapter 2 ................................................................................................. 173 
9.2 Appendix Chapter 3 ................................................................................................. 183 
9.2.1 HPLC-UV chromatography .......................................................................... 183 
9.2.2 UPLC-MS/MS chromatography ................................................................... 184 
9.2.2.1 Betalains: ............................................................................................... 184 
9.2.2.2 Flavonoids: ............................................................................................ 184 
9.2.3 Ion Chromatography ..................................................................................... 185 
9.2.4 Spectra and radiometric data ......................................................................... 186 
9.3 Appendix Chapter 4 ................................................................................................. 187 
9.3.1 NMR studies ................................................................................................. 187 
9.3.2 Preparative HPLC conditions........................................................................ 193 
9.3.3 UPLC-MS/MS chromatography ................................................................... 193 
9.3.4 Flavonoids: ................................................................................................... 194 
9.4 Appendix Chapter 5 Flavonoid analysis of crude leaf extract .................................. 195 
9.4.1 Flavonoids .................................................................................................... 195 
9.4.2 Kidney HMG analysis .................................................................................. 198 
9.4.3 Chromatograms of crude extract for animal studies ...................................... 200 
 
 
  
xiii 
 
 
List of Figures 
Figure 1.1. Vessels of the vascular system. ............................................................................. 1 
Figure 1.2. The variation in physiology of different blood vessel types .................................. 3 
Figure 1.3.  a) Tetrahydrobiopterin and b) NOS mediated generation of Nitric Oxide ............ 5 
Figure 1.4. Characteristics of the functioning healthy endothelium. ........................................ 6 
Figure 1.5. Insulin and exercise result in increased capillary recruitment and glucose (   ) 
uptake in skeletal muscle tissue ............................................................................................... 7 
Figure 1.6. Cellular activities mediated by insulin signalling .................................................. 8 
Figure 1.7. The feedback loop of persistent endothelial damage. .......................................... 13 
Figure 1.8. The digestion, absorption and cycling of cholesterol and lipids through the 
vasculature and bloodstream. ................................................................................................ 15 
Figure 1.9. The cholesterol synthesis pathway, products and the HMG Coa reductase 
inhibition by statins. .............................................................................................................. 22 
Figure 1.10. a) UPLC-MS/MS chromatogram of all m/z 600-1200 ions produced by CR leaf 
extract, b) UPLC-DAD 350nm chromatogram produced by CR leaf extract. ........................ 27 
Figure 1.11. Location of the major sites of ROS production in photosynthetic cells. ............ 31 
Figure 1.12. An overview of the photosynthetic process ....................................................... 32 
Figure 1.13. Potential electron acceptors of photosynthesis. ................................................. 32 
Figure 1.14. Schematic of ROS generation mechanisms ....................................................... 34 
Figure 1.15. The interaction of ROS generation/signalling and damage under unstressed and 
stressed conditions. ............................................................................................................... 35 
Figure 1.16. Mechanisms of ROS cellular damage ................................................................ 37 
Figure 1.17. Potential ROS generation mechanisms of transition metals ............................... 42 
Figure 1.18. (a) The primary flavonoid skeleton, (b) flavonoid families. .............................. 44 
Figure 1.19. Variation in substituents to yield various flavonol aglycones. ........................... 45 
Figure 1.20. Substituents of the C. rossii flavonoid ............................................................... 47 
Figure 2.1. Field survey locations, showing sites of soil and plant collection. ....................... 59 
Figure 2.2. Individual plant flavonoid and tannin production highlighting the intra and inter-
site variation in metabolite production between plants. ......................................................... 60 
Figure 2.3. (a) Dendogram of cluster analysis showing a small group of high flavonoid and 
tannin producing plants with a larger population of low producing plants............................. 61 
xiv 
 
 
Figure 2.4. Means of clusters 1 (    ) and 2 (     ) for (a) shelter index, (b) soil electrical 
conductivity, (c) soil Na and K concentration, (d) stomatal count, (e) osmolarity, and (f) leaf 
fluorescence characteristic. ................................................................................................... 62 
Figure 2.5. Effect of salt (NaCl) treatment on plant biomass production. .............................. 65 
Figure 2.6. (a) - Effect of NaCl concentration on number of leaves gained (n = 9 to 10) and 
individual leaf weight (size) (n = 18 to 20). (b) - leaf length and cross-sectional area as 
affected by NaCl concentration. ............................................................................................ 66 
Figure 2.7.  (a) Effect of NaCl concentration on the antioxidant activity of palisade and 
spongy leaf tissue. (b) Effect of NaCl concentration on the flavonoid production of palisade 
and sponge leaf tissue. (c) Concentration-dependency of NaCl effects on palisade antioxidant 
activity and flavonoid production, (d) Cross section of CR leaf showing the clear segregation 
between (i) palisade mesophyll and (ii) spongy parenchyma. ................................................ 69 
Figure 2.8. Determination of optimal flavonoid production conditions. ................................ 70 
Figure 2.10. Osmotic and Ionic response to NaCl concentration. .......................................... 71 
Figure 2.11. Specific ion response of leaf sap to NaCl treatment (a) palisade Na
+
, (b) palisade 
K
+
, (c) spongy Na
+
, (d) spongy K
+
. ....................................................................................... 73 
Figure 3.1. (a) Statistical summary of control and low-temperature treatments (Mean ± SEM), 
(b) temperature logs of control and low-temperature treatments. .......................................... 85 
Figure 3.2. Analysis of low and control temperature CR leaf palisade tissue. ....................... 86 
Figure 3.3. Na+ and K+ levels of low and control temperature mesophyll and palisade tissue
 .............................................................................................................................................. 87 
Figure 3.4. Analysis of UVB exposed and control CR leaf palisade tissue. (a) Gross (Mean ± 
SEM n= 30), (b) individual (Mean ± SEM n= 30), and (c) standardised to flavonoid MW 784 
(Mean ± SEM n=30), flavonoid and betalain production....................................................... 89 
Figure 3.5. Anthocyanin (a) and the Betalain aglycone (b) both possess a permanent positive 
charge as well as visible pigmentation. ................................................................................. 91 
Figure 3.6. (a) The generalised naming structure of flavonoid aglycones (Adapted from 
Crozier et al. (2009)), and b) spinacetin. ............................................................................... 92 
Figure 4.1. UPLC chromatogram of CR leaf extract ............................................................. 99 
Figure 4.2. Pirieol A, Key HMBC (       ) and NOESY (- - -) correlations. .......................... 107 
Figure 4.3. Proposed structures related to compound 1. ...................................................... 108 
xv 
 
 
Figure 5.1. Control (water) and C. rossii extract supplemented animals showed no significant 
difference (P<0.05) in (a) systolic blood pressure (SBP), (b) food consumption, (c) post-
supplementation body weight or (d) fluid Consumption. ..................................................... 117 
Figure 5.2. Representative plots and Mean ± SEM vascular response of control    (water) and 
C. rossii    supplemented animals ........................................................................................ 119 
Figure 5.3. Level of free HMG in the kidney tissue of control (water) and C. rossii 
supplemented rats. ............................................................................................................... 120 
Figure 6.1. (a) Animal weight gain, (b) daily water consumption, and (c) daily energy 
consumption of C57/BL6 mice. ........................................................................................... 132 
Figure 6.2. Plasma glucose concentration following a 2mg/kg ip bolus injection of glucose
 ............................................................................................................................................ 133 
Figure 6.3. (a) Final body weight, (b) weight gained during experiments, (c) daily energy 
consumption, and (d) daily water consumption of hyperlipidaemic Sprague-Dawley rats ... 135 
 
  
xvi 
 
 
List of Tables  
Table 1.1. A comparison of the cardiovascular protective effects provided by statin and 
flavonoid compounds ............................................................................................................ 20 
Table 1.2. Reactive Oxygen and Nitrogen Species ................................................................ 34 
Table 1.3. Approximate cost of replacing damaged cellular components .............................. 38 
Table 1.4. Plant antioxidant systems ..................................................................................... 41 
Table 2.1. HPLC conditions for flavonoid and tannin detection. ........................................... 55 
Table 2.2. Frequency (%) of prediction variable occurrence in the 10 best 4-factor prediction 
models for flavonoid, tannin and antioxidant production in C. rossii leaves. ........................ 64 
Table 2.3. Relative contribution of inorganic osmolytes (K
+
, Na
+
, Cl
-
) towards overall 
osmotic adjustment in parenchyma and mesophyll leaf tissue of C. rossii at various salinity 
treatments. ............................................................................................................................. 72 
Table 3.2. Biomass production of control and low-temperature grown plants (n = 15, 
# 
n=30)
 .............................................................................................................................................. 87 
Table 4.1. UV Spectrum analysis of the C. rossii flavonoid aglycone. ................................ 102 
Table 4.2. NMR Spectroscopic Data Structure 1 aglycone (800 MHz, d6-DMSO) ............. 105 
Table 4.3. NMR Spectroscopic Data Structure 1 Substituents (800 MHz, d6-DMSO) ........ 106 
Table 5.1. Organ weights of control (water) and C. rossii supplemented (CR) animals ...... 116 
Table 5.2. Full blood analysis and blood biochemistry of control (water) and C. rossii 
supplemented (CR) animals ................................................................................................ 118 
Table 5.3. EC50
'
s and 95% confidence intervals (CI) for noradrenaline (NA)-, sodium 
nitroprusside (SNP)- and acetylcholine (ACh)-induced  in vitro vascular (aortic) responses 
from control (water) and C. rossii (CR) treated animals. ..................................................... 118 
Table 6.1. Macronutrient dietary composition of insulin resistant (HFD) and normal (NDM) 
diets used in insulin resistant C57/BL6 mice. ...................................................................... 129 
Table 6.2 Macronutrient dietary composition of hyperlipidaemic (HL) and normal (NDR) 
diets used in hyperlipidaemic Sprague-Dawley rats. ........................................................... 130 
Table 6.3. Blood lipids of C57/BL6 mice. ........................................................................... 134 
Table 6.4. Blood lipids of Sprague-Dawley rats. ................................................................. 136 
  
xvii 
 
 
List of Appendix Figures  
Appendix Figure 2.1. Cross section of C. rossii leaf showing the clear segregation between 
(A) palisade mesophyll and (B) spongy parenchyma. ......................................................... 182 
Appendix Figure 3.1. Spectroradiometric profile of UVB experimental plants. (a) UVB lamps 
on, (b) UVB lamps off, (c) control lighting. ……………………………………………….186 
Appendix Figure 4.1. Compound 1 – evidence of line broadening in HMG methylene 
resonances. …………………………………………………………………………………187 
Appendix Figure 4.2. Compound 1 1H-13C HSQC. ………………………………………188 
Appendix Figure 4.3. Compound 1 1H-13C HMBC. ……………………………………...189 
Appendix Figure 4.4. Compound 1 1H-1D. ……………………………………………….190 
Appendix Figure 4.5. Compound 1 13C-1D. ……………………………………………...191 
Appendix Figure 4.6. The structure of Compound 1 (Pirieol A) as determined by NMR 
experimentation. …………………………………………………………………………...192 
Appendix Figure 5.1. (a) UPLC-MS/MS Chromatogram of flavonoids generating product 
ions at m/z 639, (b) UPLC-MS/MS chromatogram of flavonoid [M-H]- 783 isomers, (c) 
UPLC-DAD chromatogram at 350nm indicating the presence of flavonoid compounds. ...196 
Appendix Figure 5.2. . MS/MS fragmentation of CR representative flavonoids. …………197 
Appendix Figure 5.3. UPLC-MS/MS chromatogram of two MRM channels used for 
monitoring the presence of HMG and deuterated HMG (D3 HMG) in samples of rat kidney. 
………………………………………………………………………………………………199 
Appendix Figure 5.4. 370nm chromatogram of the crude Carpobrotus rossii extracts used for 
the in vivo studies with relevant flavonoid peaks identified. ………………………………200 
Appendix Figure 5.5. Total ion chromatogram (TIC) of the crude Carpobrotus rossii extracts 
used for the in vivo studies with relevant flavonoid peaks identified. ……………………. 201 
  
xviii 
 
 
List of Appendix Tables 
Appendix Table 2.1 Collection location of samples ............................................................ 173 
Appendix Table 2.2. Mean soil variables per site, SP 1 and STAN 1-5 sites not removed. . 177 
Appendix Table 2.3. Summary of variation in soil variables with and without clay/colluvium 
soil sites .............................................................................................................................. 178 
Appendix Table 2.4. The best 1 to 4 factor regression models for prediction of flavonoid, 
tannin and antioxidant production in C. rossii leaves. ......................................................... 179 
Appendix Table 2.5. Correlations between biomass, flavonoid and antioxidant variables 
measured at the whole plant scale during NaCl dosing experiment. Correlation assessed with 
Pearson correlation
a
. ............................................................................................................ 180 
Appendix Table 2.6. Correlations between biomass, flavonoid and antioxidant variables 
measured at the individual leaf scale during NaCl dosing experiment. Correlation assessed 
with Pearson correlation
a
. .................................................................................................... 181 
Appendix Table 3.1 Solvent conditions for HPLC-UV Chromatography……………....183 
Appendix Table 5. Preparative HPLC conditions for the purification of the 784Da flavonoid
 ............................................................................................................................................ 193 
  
xix 
 
 
 
  
A selection of C. rossii photographs taken by the candidate during the course of their PhD  studies 
xx 
 
 
PhD overview 
"Metabolic syndrome" refers to the triumvirate of obesity-related, cardiovascular diseases 
such as hyperlipidaemia, type 2 diabetes, atherosclerosis and hypertension. The worldwide 
prevalence of these diseases have increased to such an extent that they are now the leading 
cause of human morbidity and mortality. Metabolic syndrome is characterised by elevated 
levels of plasma lipids, hyperglycaemia, compromised insulin signalling, excessive 
production of reactive oxygen species (ROS) and a vasculature that is in a persistently 
inflamed state. Because of the increasing prevalence of these diseases, considerable research 
effort has gone into understanding the disease processes and developing appropriate 
therapies. Two metabolic syndrome targets which have been identified and for which 
therapeutics have been successfully developed are hyperlipidaemia and hyperglycaemia.  
A common target of the lipid-lowering therapies is the HMG-CoA reductase enzyme which 
catalyses the rate limiting step in the cholesterol synthesis pathway namely the conversion of 
3-hydroxy-3-methylglutaric acid coenzyme-A (HMG-CoA) to mevalonate. Statins are the 
primary class of drugs with this HMG-CoA inhibiting ability. Polyphenolic compounds 
produced by plants have also been shown to have hypolipidaemic activity by inhibiting 
HMG-CoA as well as other enzymes involved in the processes of lipid manufacture and 
delivery to cells. Polyphenolic compounds have also been shown to improve the glucose 
status of diseased subjects by improving vascular health, improving insulin signalling and 
glucose uptake into muscle. Of these plant-derived polyphenolic compounds, members of the 
flavonoid sub-family been shown to be particularly successful in treating both 
hyperlipidaemia and hyperglycaemia.   
Carpobrotus rossii (CR) is a succulent halophyte native to Australia and commonly found 
growing along the coastal margins of southern Australia. The plant has a history of use by 
both the indigenous aboriginal population and early Tasmanian settlers. CR was reportedly 
consumed as a food, to treat gastrointestinal upsets, and applied topically for the treatment of 
bites and scratches. Preliminary investigations conducted at the University of Tasmania have 
shown that crude extracts from its leaves inhibit platelet aggregation, inflammatory cytokine 
release (interleukin-1-beta, tumour necrosis factor-alpha) and lipid oxidation in vitro 
(Geraghty et al., 2011). This activity is believed to be due to the flavonoid compounds that 
xxi 
 
 
the plant produces in its leaves. Several of these flavonoids have a known HMG-CoA 
inhibitor 3-hydroxy-3methylglutaric acid (HMG) present as a substituent (Jager, 2009).The 
presence of this moiety, in conjunction with the known hypoglycaemic and hypolipidaemic 
activities of other flavonoids, mean that the consumption of CR flavonoids could potentially 
improve endothelial health, cardiovascular function and health via a combination of effects 
related to both their flavonoid and statin properties. 
In planta, the primary function of flavonoids appears to be as antioxidants, and their 
production has been shown to be induced under a suite of conditions which cause the plant to 
experience oxidative stress. The ROS generation and signalling process in planta are 
complex, and the effect of environmental conditions on a plant's redox status, and hence 
flavonoid production, is likely to vary between species. The effects of environment on 
flavonoid product has not been previously investigated for CR. The flavonoid structures 
described in chapter 4 are extremely complex, and based on informal discussions with an 
organic chemist familiar with similar compounds, not easily amenable to synthesis. As such, 
the ability to produce sufficient material and improve the efficiency of their production e.g. 
increasing biomass or increasing flavonoid concentration by the modification of 
environmental parameters is a key component of overall CR pharmaceutical and nutraceutical 
investigations. 
This thesis has involved using techniques relevant to the disciplines of pharmacology, 
organic chemistry and plant physiology. The primary aims were to investigate the 
pharmaceutical and nutraceutical potential of the flavonoids derived from CR leaves. To do 
this, several basic questions were addressed, namely:  
1. What effect do environmental conditions have on metabolite production,  
2. What is the structure of the CR flavonoids,  
3. Is the consumption of CR leaf derived extracts safe, and, 
4. Do the CR leaf flavonoids possess pharmacological activity in metabolic 
syndrome, specifically an improvement in either glycaemic or lipid 
profile.  
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A suite of novel findings which pave the way for further study of this plant are the result of 
this research. The body of the thesis is presented as a series of articles for publication, of 
which three are published at the time of thesis submission.  
 
 
The published articles are as follows: 
PIRIE, A. D., DAVIES, N. W., AHUJA, K. D. K., ADAMS, M. J., SHING, C. M., 
NARKOWICZ, C., JACOBSON, G. A. & GERAGHTY, D. P. 2014. A crude extract 
from Carpobrotus rossii (pigface) lowers cholesterol in healthy rats. Food and 
Chemical Toxicology, 66, 134-139. 
PIRIE, A., PARSONS, D., RENGGLI, J., NARKOWICZ, C., JACOBSON, G. A. & 
SHABALA, S. 2013. Modulation of flavonoid and tannin production of Carpobrotus 
rossii by environmental conditions. Environmental and Experimental Botany, 87, 19-
31. 
PIRIE, A., SHABALA, S., PARSONS, D., NARKOWICZ, C., JACOBSON, G. & 
RENGGLI, J. 2011. Ecophysiology of Carpobrotus rossii in Tasmania: Linking 
plant's antioxidant activity with a natural habitat. Ecological Questions, 14, 91-93. 
In addition to these published manuscripts several other articles are currently undergoing the 
peer-review process. 
Due to the multidisciplinary nature of this work, the literature review is quite detailed 
covering cardiovascular physiology the associated disease processes, plant physiology and 
organic chemistry, as appropriate. This has been done to ensure that all examiners have 
sufficient grounding to understand the work described in this thesis when it is outside their 
area of expertise.  
Plant Physiology (Chapters 2 and 3) 
The survey investigating flavonoid production by wild CR (77 plants from 16 sites around the 
coastline of Tasmania) showed that conditions known to induce stress in planta were 
associated with altered flavonoid production. Under conditions of sub- and supra-optimal 
salinity (<50mM, >100mM NaCl), biomass production was reduced, whilst flavonoid 
